BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SciLifeLab - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SciLifeLab
X-ORIGINAL-URL:https://www.scilifelab.se
X-WR-CALDESC:Events for SciLifeLab
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20250225T120000
DTEND;TZID=Europe/Stockholm:20250225T130000
DTSTAMP:20260531T055016
CREATED:20250206T095146Z
LAST-MODIFIED:20250210T141359Z
UID:180838-1740484800-1740488400@www.scilifelab.se
SUMMARY:PULSE Challenge: ML/AI approaches for designing proximity-inducing small molecules  – PROTAC cell permeability and bioavailability
DESCRIPTION:The seminar series PULSE Challenge is connected to the MSCA co-funded* postdoctoral program SciLifeLab PULSE\, that will train 48 future leaders in life sciences. The program focuses on innovative\, fundamental and translational research carried out in supportive and diverse academic and industrial environments\, preparing postdocs with necessary skills for long-term career sustainability. Click HERE to find out more about SciLifeLab PULSE \n\n\n\n\n\n\n\nOn-line event via Zoom \n\n\n\nRegister Here\n\n\n\n\n\n\n\n\n\n\n\n\n\nPresenters: Prof. Jan Kihlberg & Assoc. prof. Vasanthanathan PoongavanamUppsala University\, Sweden \n\n\n\nAbstract:Most PROTACs which have a “druglike” oral bioavailability (>5%) are based on a CRBN E3-ligase ligand\, but a few VHL PROTACs also display >5% bioavailability. Use of 2D descriptors places oral drugs\, CRBN and VHL PROTACs in different parts of chemical space\, while the use of 3D descriptors indicates that the chemical spaces overlap. Use of 3D descriptors may therefore enhance the probability of discovering PROTACs with satisfactory oral bioavailability \n\n\n\nWe have studied CRBN and VHL PROTACs by NMR spectroscopy and MD simulations. These studies revealed that the propensity of the PROTACs to adopt folded and semi-folded conformations with low solvent – accessible 3D polar surface area correlated to higher cell permeability. The length\, chemical nature and flexibility of the linker was found to be essential for allowing intramolecular hydrogen bonds\, π–π interactions and van der Waals interactions to stabilize (semi)folded conformations for permeable PROTACs in a membrane-like environment. \n\n\n\nUse of MD simulations for prediction of the conformations and properties of PROTACs is time consuming. However\, classification models that were developed by machine learning using 2D descriptors allowed differentiation between VHL PROTACs that had high or low cell permeability. Such models can be integrated as effective filters to prioritize PROTACs for synthesis in the design process. Nevertheless\, certain challenges remain\, including the imbalanced nature of datasets\, and model interpretability. Addressing these limitations in future studies will be crucial for maximizing the full potential of machine learning in PROTAC design. \n\n\n\nBiographies:Jan Kihlberg holds a chair in Organic Chemistry at Uppsala University\, Sweden since 2013. His key research interests are to understand what properties convey cell permeability\, aqueous solubility and target binding to drugs such as PROTACs and macrocycles in the beyond rule of 5 space and to translate this knowledge into guidelines for design. He has published more than 200 peer–reviewed publications and book chapters. He establishing his independent research group at Lund University in 1991\, became full professor in Bioorganic Chemistry at Umeå University in 1996\, then moved to AstraZeneca R&D in Gothenburg in 2003 while maintaining a research group at Umeå University. At AstraZeneca Prof. Kihlberg held the role as Director\, Head of Medicinal Chemistry for seven years. \n\n\n\nVasanthanathan Poongavanam is a computational chemistry and AI expert at the DDD Platform\, SciLifeLab\, Uppsala University\, Sweden. His research focuses on applying computational chemistry and AI methodologies to accelerate drug discovery projects. He has authored more than 60 scientific publications\, including research articles\, reviews\, and book chapters.
URL:https://www.scilifelab.se/event/pulse-challenge-ml-ai-approaches-for-designing-proximity-inducing-small-molecules-protac-cell-permeability-and-bioavailability/
LOCATION:Online event via Zoom
CATEGORIES:Event
ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2025/02/Bild1-e1770905208628.png
END:VEVENT
END:VCALENDAR